Internal Medicine, Medical Oncology · Enid, OK
NPI
1255472122
Since 2007
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
600 S Monroe St
Enid, OK, 73701
Phone (580) 977-1950
Groups this clinician bills Medicare through
Medicare paid, 2024
$158K
1,916 services
Medicare patients, 2024
618
Average age 74
Drug cost, 2024
$2.0M
1,499 prescriptions
Company payments, 2025
$481
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sumbal Nabi was code 99214 (office e&m - established), 962 times for 508 patients. In total Sumbal Nabi billed 1,916 services in 10 codes, and Medicare paid $158K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-03-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 962 | 508 | $62.92 | $61K |
| 99215 Office E&M - Established | Facility | 754 | 152 | $100.63 | $76K |
| 99205 Office E&M - New | Facility | 147 | 147 | $116.85 | $17K |
| 99223 Hospital E&M - Initial | Facility | 15 | 14 | $120.18 | $1,803 |
By year: 2022 $161K for 1,789 services; 2023 $158K for 1,795 services; 2024 $158K for 1,916 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sumbal Nabi prescribed most often to Medicare patients was Anastrozole, with 234 prescriptions and refills. In total Sumbal Nabi wrote 1,499 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 234 | 495 | 56 | $6,565 |
| Ondansetron Odt Ondansetron | 92 | 92 | 50 | $4,859 |
| Hydroxyurea Generic | 78 | 123 | 17 | $1,401 |
| Gabapentin Generic | 70 | 85 | 14 | $738 |
| Oxycodone Hcl Generic | 62 | 62 | 19 | $1,455 |
| Potassium Chloride Generic | 61 | 107 | 20 | $776 |
| Prednisone Generic | 57 | 70 | 28 | $400 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 49 | 53 | 14 | $1,343 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 46 | 46 | 33 | $643 |
| Tramadol Hcl Generic | 34 | 34 | 15 | $179 |
| Fentanyl Generic | 30 | 30 | Under 11 | $2,332 |
| Tamoxifen Citrate Generic | 30 | 52 | Under 11 | $802 |
| Pantoprazole Sodium Generic | 28 | 34 | Under 11 | $77.2 |
| Lorazepam Generic | 26 | 26 | Under 11 | $175 |
| Levothyroxine Sodium Generic | 24 | 44 | Under 11 | $193 |
Brand drugs: 215 claims; generic drugs: 1,284 claims; opioid claims: 198.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sumbal Nabi $481 ($481 in general payments such as food, travel and fees) from 12 companies. The largest payer was Janssen Biotech, Inc. with $100.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 4 | $100 |
| Intuitive Surgical, Inc. ISRG | 1 | $73.96 |
| Genzyme Corporation SNY | 3 | $61.89 |
| Pfizer Inc. PFE | 2 | $57.51 |
| Sumitomo Pharma America, Inc. 4506.T | 2 | $42 |
| Aveo Pharmaceuticals, Inc. | 1 | $30.42 |
| Caris MPI, Inc. | 1 | $26.32 |
| Alexion Pharmaceuticals, Inc. AZN | 1 | $22.41 |
| Incyte Corporation INCY | 1 | $21.68 |
| Merck Sharp & Dohme LLC MRK | 1 | $15.88 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.